Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immune Signature and Microbial Environment

NCT07698769 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT07698769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immune Signature and Microbial Environment
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Overall status
Recruiting
Start date
December 5, 2024
Completion date
December 5, 2026
Enrollment
110 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal cytokine profile of patients (type i and iii interferons, pro-inflammatory cytokines)